Rating Change
Barclays analysts reiterated a Overweight rating on Natera, Inc. (NASDAQ:NTRA) on June 24, 2026.
reiterateNASDAQ:NTRA
Barclays Reiterates Overweight Rating on Natera, Inc. (NTRA)
Rating Change Barclays analysts reiterated a Overweight rating on Natera, Inc. (NASDAQ:NTRA) on June 24, 2026. Market Context Natera, Inc.
Market Context
Natera, Inc. operates in the Healthcare sector. The stock currently trades at $259.97 with a market capitalization of $31.9B. The stock has gained 52.6% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Natera, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Natera, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jun 24, 2026 | BTIG | Buy | N/A |
| Jun 24, 2026 | Barclays | Overweight | N/A |
| Jun 23, 2026 | BTIG | Buy | N/A |
| Jun 11, 2026 | RBC Capital | Outperform | N/A |
| Jun 05, 2026 | Goldman Sachs | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View NTRA Stock Page
Frequently Asked Questions
What does a Overweight rating mean for NTRA?
A Overweight rating from Barclays reflects the analyst's outlook on Natera, Inc. (NASDAQ:NTRA). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the NTRA forecast page.